Within a few weeks, millions of doses of Chinese CanSino and a single-dose Indian CoviShield coronavirus vaccine will arrive in Hungary, according to a response sent by the press department of the Ministry of Foreign Affairs and Trade. az atv.hu question. According to the ministry, there is no contract for all of this yet, but negotiations are underway.
On Monday, Cecília Müller, the chief medical officer, announced that OGYÉI had authorized the use of the vaccine in Hungary. CanSino contains human adenovirus 5, the vector by which information is introduced into cells. The Covishield vaccine is almost identical to the AstraZeneca vaccine. The CanSioBio vaccine protects 65.3 percent of Covid-19, according to Chinese results, and 91 percent protects against severe disease, according to clinical trials in Pakistan. AstraZeneca serum is 79 percent effective, according to a U.S. drug regulatory, FDA study.
OGYÉI has indicated that the two vaccines can only be used after authorization and laboratory testing and must ensure that the vaccines are safe, effective and of adequate quality.
– .
